Affiliation:
1. Christopher Kohlenberg Department of Perinatal Ultrasound Nepean Hospital Penrith New South Wales Australia
2. Department of Microbiology and Infectious Diseases New South Wales Health Pathology, Nepean Blue Mountains Pathology Service Penrith New South Wales Australia
3. Nepean Clinical School, Faculty of Medicine and Health University of Sydney Sydney New South Wales Australia
4. Clinical Links Using Evidence‐based Data (CLUED) Pty Ltd Sydney New South Wales Australia
Abstract
BackgroundInfection of the amniotic cavity is an important driver and/or consequence of preterm prelabour rupture of membranes (PPROM). Prediction of infection is challenging, limiting guidance for interventions during the antenatal period. Infection typically triggers a host inflammatory response, and non‐invasive indirect markers of the maternal or fetal inflammatory response have been reported in the context of PPROM and intra‐amniotic infection. Some of these markers have also been tested in amniotic fluid (AF) samples.AimsThis study compared markers of the inflammatory response in women with PPROM against the outcome standard of histological chorioamnionitis (HCA) or funisitis (FUS).MethodsSearches were conducted for studies reporting diagnostic test sensitivity and specificity for proven HCA or FUS in pregnant women with PPROM after 20 weeks’ gestation. Weighted mean pooled sensitivity (Se), specificity (Sp), positive predictive value, negative predictive value, diagnostic odds ratio and 95% confidence intervals were calculated for each of the selected diagnostic tests.ResultsExcept ultrasonographic detection of fetal thymic involution, almost all index tests analysed showed relatively low sensitivity. Maternal white cell count, interleukin‐6 (IL‐6) and AF IL‐6 had credible specificity. Testing of AF markers, while more consistent than serum markers, showed no clear diagnostic accuracy improvement.ConclusionsThere is a clear lack of evidence for the reliability of any individual diagnostic test to assist in the detection of HCA or FUS in women with PPROM. Combining several markers into a predictive model for improved diagnosis may be worth investigating.
Reference66 articles.
1. Premature rupture of the fetal membranes;Parry S;N Engl J Med,1998
2. The preterm prediction study: Prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. The National Institute of Child Health and Human Development maternal‐fetal medicine units network;Mercer BM;Am J Obstet Gynecol,2000
3. Treatments of preterm premature rupture of the membranes: A meta‐analysis;Ohlsson A;Am J Obstet Gynecol,1989
4. The fetal inflammatory response syndrome: The origins of a concept, pathophysiology, diagnosis, and obstetrical implications;Jung E;Semin Fetal Neonatal Med,2020
5. Acute chorioamnionitis and funisitis: Definition, pathologic features, and clinical significance;Kim CJ;Am J Obstet Gynecol,2015